Questions discussed in this category
Can you elaborate on reasons for a non-quantifiable SPEP and how does one follow the paraprotein?
Can you explain when would you consider light chain amyloidosis work up with fat pad biopsy?
For example, how do you address tendency to "over-order" these tests in patients with common aches/pains but no structural abnormalities on advanced i...
Would you do a 24-hour urine and echocardiogram in all of these patients? Cardiac biomarkers, PT/PTT, or any other such blood tests?
E.g. a patient with monoclonal protein with mild light chain ratio elevation. Do we need to get a BM biopsy in all such patients?
How do you decide how long to continue?
Is a repeatedly abnormal serum immunofixation all it takes for MGUS?
For example, in cold agglutinin disease or AIHA, antibodies can be detected via DAT, but are often not observed on assays for monoclonal gammopathies.
22687218722112018953182281327115119149011092414072117991141491086142
Papers discussed in this category
JCO Oncol Pract, 2020 Aug 21
Lancet Oncol, 2019 Oct 23
N Engl J Med,
Br J Haematol, 2021 Aug 15
Blood, 2022 Dec 08
Haematologica, 2013-01
The Lancet. Haematology, 2015 May 06
European respiratory review : an official journal of the European Respiratory Society, 2017 Sep 06
Mayo Clinic proceedings, 2017-06
Blood Cancer J, 2022 Sep 14
Cancer, 2020 Jan 08